U.S., June 27 -- ClinicalTrials.gov registry received information related to the study (NCT07039942) titled 'French Prospective Multicentric Study in Real World' on June 18.
Brief Summary: The purpose of this postmarket clinical investigation is to evaluate the levels of glycemic control, quality of life, and satisfaction, as well as the patient experience, and acute diabetes complication rates provided by the Omnipod 5 Automated Insulin Delivery System (referred to as the Omnipod 5 System) in a real-world setting.
Study Start Date: July 01
Study Type: OBSERVATIONAL
Condition:
Diabetes
Diabetes Mellitus
Type 1 Diabetes
Intervention:
DEVICE: Omnipod 5
The Omnipod 5 Automated Insulin Delivery System (Omnipod 5 System) is a tubeless in...